Personalized Caries Management Versus Standard of Care for Preventing Incidence of Caries in Young Egyptian Adults
NCT ID: NCT03731780
Last Updated: 2018-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
81 participants
INTERVENTIONAL
2018-12-31
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Different Preventive Regimens in Cariogram Parameters and DMF Scores of High Caries Risk Patients: A Randomized Control Trial
NCT04032184
Miswak Versus Standard Measures to Prevent the Incidence of Caries Young Egyptian Adults: A Randomized Controlled Clinical Trial
NCT03732040
Efficacy and Cost-effectiveness of Different Caries Preventive Protocols
NCT05962632
A Clinical and Microbiological Assessment of the Efficacy of Chemo-mechanical Caries Removal Versus Conventional Caries Removal Methods in Children: Randomized Controlled Clinical Trial
NCT06531148
Correlation Between Caries Experience in Primary Molars and First Permanent Molars
NCT03671200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: This project will be designed to test the null hypothesis that there is no significant difference between the new personalized caries-control treatment protocol and existing standard caries treatment protocol, and to test the alternative hypothesis that the new personalized treatment protocol will be superior to the standard preventive measures
Primary objective: is to measure the incidence of new caries lesions
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Personalized Treatment
Intervention by (standard preventive measures + targeting individual caries risk factors)
Personalized Treatment
Targeting individual caries risk factors
Chlorhexidine and Rremineralization
Intervention is (chlorhexidine + Remineralizing agent + standard preventive measures)
Chlorhexidine and Remineralization
chlorhexidine mouth wash and remineralizing agent
Control
standard preventative measures (tooth brushing, fluoride tooth paste, interdental cleaning)
Control
Control is standard preventive measures (tooth brushing, fluoride tooth paste, interdental cleaning)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalized Treatment
Targeting individual caries risk factors
Chlorhexidine and Remineralization
chlorhexidine mouth wash and remineralizing agent
Control
Control is standard preventive measures (tooth brushing, fluoride tooth paste, interdental cleaning)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18-25 years
3. Males or Females
4. Patients approving to participate in the study -
Exclusion Criteria
* Current periodontitis (sites of probing pocket depth ≥ 5 mm)
* Allergy to any of the ingredients of the study products
* Evidence of parafunctional habits
* Dysfunction of temporomandibular joint
* Use of antibiotics in the previous 30 days
* Patients with developmental dental anomalies
* Patients with removable prosthesis
* Patients with Orthodontic appliance
* Periapical Abscess or Fistula and exposed pulps.
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherif Khadr
Doctoral Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fawzi, PhD
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018cons1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.